AFP and neoplasm: In clinical practice of TGCTs, the three common tumor markers including Alpha‐fetoprotein (AFP), b‐human chorionic gonadotrophin (b‐HCG), and lactate dehydrogenase (LDH), are used for diagnosis, risk assessment, and determining patient prognosis.3